CYTOTEC – First responses to the intended withdrawal from the market in France
by International Campaign for Women's Right to Safe Abortion
Dec 5, 2017
Abortion providers in France are mobilising to retain Cytotec for abortion (or an affordable substitute). The decision to withdraw Cytotec from the market in France following complaints that it had caused problems for several women who had been given too high a dose to induce labour has led to an outcry among those who support universal access to safe abortion in France, such as the National Association of Clinics for Abortion and Contraception and the French National College of Obstetricians & Gynaecologists.
The group REIVOC, which consists of all the abortion providers in the Occitanie Region in France, including GPs, gynaecologists, midwives, and family planning advocates, called the decision hypocritical: “Cytotec is indispensible for inducing abortion. While there is an alternative, Gymiso, it is 40 times more expensive. Everyone knows Cytotec is used for abortion even if that is not one of its approved indications. Instead of withdrawing it, it is urgent that a generic substitute is found.”
Continued at source: http://www.safeabortionwomensright.org/cytotec-first-responses-to-the-intended-withdrawal-from-the-market-in-france/